Matches in Wikidata for { <http://www.wikidata.org/entity/Q102209972> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q102209972 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 16ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q102209972 description "artículu científicu espublizáu en payares de 2020" @default.
- Q102209972 description "im November 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q102209972 description "scientific article published on 16 November 2020" @default.
- Q102209972 description "wetenschappelijk artikel" @default.
- Q102209972 description "наукова стаття, опублікована 16 листопада 2020" @default.
- Q102209972 description "գիտական հոդված հրատարակված 2020 թվականի նոյեմբերի 16-ին" @default.
- Q102209972 name "Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab" @default.
- Q102209972 name "Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab" @default.
- Q102209972 name "Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab" @default.
- Q102209972 type Item @default.
- Q102209972 label "Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab" @default.
- Q102209972 label "Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab" @default.
- Q102209972 label "Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab" @default.
- Q102209972 prefLabel "Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab" @default.
- Q102209972 prefLabel "Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab" @default.
- Q102209972 prefLabel "Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab" @default.
- Q102209972 P1433 Q102209972-A03F8883-474E-4199-A2AD-CB3C11672E19 @default.
- Q102209972 P1476 Q102209972-D5782F9E-4AE8-4999-AC2D-F7A6F910B56E @default.
- Q102209972 P2093 Q102209972-5A223B59-C27E-4EF7-B541-2C3B735873DB @default.
- Q102209972 P2093 Q102209972-8DC3E251-48D4-45C2-ADBA-77955321B71C @default.
- Q102209972 P2093 Q102209972-90D0E0E2-5A1C-4A4F-91DF-D0D3EF899B14 @default.
- Q102209972 P2093 Q102209972-99B68467-2750-49D6-867C-8F804D1C8497 @default.
- Q102209972 P2093 Q102209972-DAD7C198-5D1D-44C2-9137-65A1C85B7C69 @default.
- Q102209972 P31 Q102209972-831C08F7-BB3F-4F7F-9061-C7182B0A6F23 @default.
- Q102209972 P356 Q102209972-E6D9E1E8-DFC7-473D-B56B-E5FCF44C3A08 @default.
- Q102209972 P577 Q102209972-87F1C111-1E35-4220-8114-A06BF3301B7E @default.
- Q102209972 P698 Q102209972-47FCDE9B-B209-43B9-95B7-1C9E1E05F1EF @default.
- Q102209972 P356 J.ENDINU.2020.07.005 @default.
- Q102209972 P698 33214127 @default.
- Q102209972 P1433 Q63882893 @default.
- Q102209972 P1476 "Diabetes mellitus associated with immune checkpoint inhibitors treatment: A clinical case by atezolizumab" @default.
- Q102209972 P2093 "Cristóbal Morales Portillo" @default.
- Q102209972 P2093 "Isabel Serrano Olmedo" @default.
- Q102209972 P2093 "María Asunción Martínez Brocca" @default.
- Q102209972 P2093 "María Del Castillo Tous Romero" @default.
- Q102209972 P2093 "Pablo Rodríguez de Vera Gómez" @default.
- Q102209972 P31 Q13442814 @default.
- Q102209972 P356 "10.1016/J.ENDINU.2020.07.005" @default.
- Q102209972 P577 "2020-11-16T00:00:00Z" @default.
- Q102209972 P698 "33214127" @default.